Literature DB >> 15698840

Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo.

Daniel Céfaï1, Eleonora Simeoni, Kaethy Mujynya Ludunge, Robert Driscoll, Ludwig K von Segesser, Lukas Kappenberger, Giuseppe Vassalli.   

Abstract

Endothelial cells (ECs) in normal vessels are poorly transducible by retroviral vectors, which require cell division for gene transduction. Among retroviruses, lentiviruses have the unique ability to integrate their genome into the chromatin of nondividing cells. Here we show that multiply attenuated, self-inactivating, lentiviral vectors transduce both proliferating and growth-arrested human umbilical vein ECs (HUVECs), human coronary artery ECs (HCAECs), and human coronary artery smooth muscle cells (HCASMCs), with high efficacy. Lentiviral vectors containing the enhanced green fluorescence protein (EGFP) transgene driven by either the cytomegalovirus or the elongation factor-1alpha promoter, but not the phosphoglycerate kinase promoter, directed high-level EGFP expression in endothelial and smooth muscle cells. The endothelium-specific Tie2 promoter also directed transgene expression in ECs. Re-insertion of cis-acting sequences from pol of human immunodeficiency virus type 1 (HIV-1) into the vectors improved transgene expression. A lentiviral vector containing the vascular endothelial growth factor transgene promoted EC proliferation and sprouting in vitro. In vivo gene transfer was studied by lumenal infusion of vector containing solutions into rat carotid arteries. Lentivirus-mediated EGFP gene transfer was observed in approximately 5% of ECs. Lentiviral vectors containing the LacZ transgene achieved detectable beta-galactosidase activity in rat arteries, albeit at a lower level compared with adenoviral vectors. This difference was mainly due to the lower concentration of lentiviral vector preparations. Lentivirus-mediated gene transfer was associated with minimal neointimal hyperplasia and scant inflammatory cell infiltrates in the media and adventitia. These observations indicate that lentiviral vectors may be useful for genetic modifications of vascular cells in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15698840     DOI: 10.1016/j.yjmcc.2004.11.031

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  11 in total

1.  Integrase-deficient lentiviral vectors mediate efficient gene transfer to human vascular smooth muscle cells with minimal genotoxic risk.

Authors:  Helen E Chick; Ali Nowrouzi; Raffaele Fronza; Robert A McDonald; Nicole M Kane; Raul Alba; Christian Delles; William C Sessa; Manfred Schmidt; Adrian J Thrasher; Andrew H Baker
Journal:  Hum Gene Ther       Date:  2012-10-26       Impact factor: 5.695

Review 2.  Gene therapy for the prevention of vein graft disease.

Authors:  Kevin W Southerland; Sarah B Frazier; Dawn E Bowles; Carmelo A Milano; Christopher D Kontos
Journal:  Transl Res       Date:  2012-12-27       Impact factor: 7.012

3.  Novel Paracrine Functions of Smooth Muscle Cells in Supporting Endothelial Regeneration Following Arterial Injury.

Authors:  Jun Ren; Ting Zhou; Vijaya Satish Sekhar Pilli; Noel Phan; Qiwei Wang; Kartik Gupta; Zhenjie Liu; Nader Sheibani; Bo Liu
Journal:  Circ Res       Date:  2019-04-12       Impact factor: 17.367

4.  Retargeting of gene expression using endothelium specific hexon modified adenoviral vector.

Authors:  Sergey A Kaliberov; Lyudmila N Kaliberova; Zhi Hong Lu; Meredith A Preuss; Justin A Barnes; Cecil R Stockard; William E Grizzle; Jeffrey M Arbeit; David T Curiel
Journal:  Virology       Date:  2013-10-15       Impact factor: 3.616

5.  Sustained, localized transgene expression mediated from lentivirus-loaded biodegradable polyester elastomers.

Authors:  Michele C Jen; Kevin Baler; Ashleigh R Hood; Seungjin Shin; Lonnie D Shea; Guillermo A Ameer
Journal:  J Biomed Mater Res A       Date:  2012-10-15       Impact factor: 4.396

Review 6.  Immunotherapeutic approaches for glioma.

Authors:  Hideho Okada; Gary Kohanbash; Xinmei Zhu; Edward R Kastenhuber; Aki Hoji; Ryo Ueda; Mitsugu Fujita
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

7.  Development of viral vectors for use in cardiovascular gene therapy.

Authors:  Paul D Williams; Parisa Ranjzad; Salik J Kakar; Paul A Kingston
Journal:  Viruses       Date:  2010-01-27       Impact factor: 5.818

Review 8.  Gene therapy for stroke: 2006 overview.

Authors:  Yi Chu; Jordan D Miller; Donald D Heistad
Journal:  Curr Hypertens Rep       Date:  2007-03       Impact factor: 4.592

9.  Suppression of neointimal hyperplasia following angioplasty-induced vascular injury in pigs infected with swinepox virus.

Authors:  Takeshi Shimamura; David Jeng; Alexandra Lucas; Karim Essani
Journal:  Open Virol J       Date:  2012-10-15

10.  Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer.

Authors:  Marco Ranzani; Daniela Cesana; Cynthia C Bartholomae; Francesca Sanvito; Mauro Pala; Fabrizio Benedicenti; Pierangela Gallina; Lucia Sergi Sergi; Stefania Merella; Alessandro Bulfone; Claudio Doglioni; Christof von Kalle; Yoon Jun Kim; Manfred Schmidt; Giovanni Tonon; Luigi Naldini; Eugenio Montini
Journal:  Nat Methods       Date:  2013-01-13       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.